Cybear Group Receives Notification of Possible NASDAQ Delisting.

Business Editors & Health/Medical Writers

BOCA RATON, Fla.--(BUSINESS WIRE)--March 4, 2002

Andrx Corporation's Cybear Group (Nasdaq:CYBA) ("Cybear Group") today announced that it has received notification from Nasdaq Stock Market that, for the last 30 consecutive trading days, Cybear Group common stock has not maintained a minimum market value of publicly held shares ("MVPHS") of $5,000,000 and a minimum bid price per share of $1.00 as required for continued inclusion under Nasdaq's Marketplace Rules 4450(a)(2) and 4450(a)(5), respectively. Cybear Group has been given 90 calendar days, or until May 23, 2002, to regain a MVPHS of at least $5,000,000 as well as a bid price of at least $1.00 per share, at the market close, for a minimum of 10 consecutive trading days. If Cybear Group does not meet these criteria by May 23, 2002, Nasdaq will provide written notification that Cybear Group's securities are subject to delisting. At that time, Andrx Corporation may appeal Nasdaq's determination as it relates to the Cybear Group to a listing qualifications panel or apply for a transfer of its securities to the Nasdaq Small Cap Market. If Andrx Corporation applies for an appeal or transfer for Cybear Group, there is no assurance that either action would be granted.

Nasdaq's notification regarding Cybear Group's listing does not affect Andrx Corporation-Andrx Group Common Stock (Nasdaq:ADRX).

About Cybear Group

The Cybear Group includes Cybear Inc., Cybear Acquisition Corporation, formerly certain assets of AHT Corporation, and Mediconsult.com, Inc. and its subsidiaries. Headquartered in Boca Raton, Florida, the Cybear Group's products and technology are designed to allow the Internet to be used to improve the efficiency of clinical, administrative and communications tasks in the healthcare industry. The Cybear Group uses multiple networks, including its own secure private network, to provide access to the Internet, email, and productivity applications that are available on a transaction or subscription basis to physicians, physician organizations and hospitals. Product offerings also include a variety of healthcare products available to physicians through the Internet, online applications such as the Physicians' Online Web portal, business tools for hospital messaging, lab orders and results, streamlined purchasing, prescription writing, claims processing, eligibility verification, formulary-compliance, credentialing, and physician-patient communications via the Internet. Through Cybearclub LC, Cybear Group's joint venture with Andrx Corporation, Cybear Group sells and distributes healthcare products to physicians through the Internet.

Forward-looking statements (statements which are not historical facts) in this release are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. For this purpose, any statements contained in this report that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the generality of the foregoing, words such as "may," "will," "to," "expect," "believe," "anticipate," "intend," "could," "would," "estimate," or "continue" or the negative or other variations thereof or comparable terminology are intended to identify forward-looking statements. Investors are cautioned that all forward-looking statements involve risk and uncertainties. Andrx common stock and Cybear common stock are classes of common stock of Andrx Corporation, therefore Andrx and Cybear stockholders are subject to the risks and uncertainties described in Andrx Corporation's filings with the U.S. Securities and Exchange Commission, including Andrx Corporation's Annual Report on Form 10-K for the year ended December 31, 2000 and its Quarterly Reports on Form 10-Q for the quarters ended March 31, 2001, June 30, 2001 and September 30, 2001.

This release and additional information about Andrx Corporation are also available on the Internet at: http://www.andrx.com